Understanding how kidney transplant patients respond to COVID vaccines
Deciphering the Molecular Mechanisms of Response to COVID Vaccine in Kidney Transplant Recipients
This study is looking at how kidney transplant patients respond to COVID-19 vaccines compared to other transplant patients, to help understand why they might not respond as well and find better ways to protect them.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Palo Alto Veterans Instit for Research NIH-funded |
| Lab location | 1 site (Palo Alto, United States) |
| Project ID | NIH-10911040 on NIH RePORTER |
What this research studies
This research investigates the immune responses of kidney transplant recipients to COVID-19 vaccines, focusing on how their unique immune systems react compared to other transplant groups, like liver recipients. By analyzing blood samples from these patients, the study aims to uncover the molecular mechanisms that influence vaccine effectiveness. The researchers will explore both cellular and antibody responses to better understand why kidney transplant patients may have a weaker response to vaccination. This knowledge could lead to improved vaccination strategies for this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received a kidney transplant and are eligible for COVID-19 vaccination.
Not a fit: Patients who have not undergone kidney transplantation or those who are not eligible for COVID-19 vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance vaccine effectiveness and safety for kidney transplant recipients, ultimately improving their health outcomes.
How similar studies have performed: Previous research has shown varying immune responses to COVID-19 vaccines in transplant populations, indicating that this area of study is both relevant and necessary for improving patient care.
Where this research is happening
Palo Alto, United States
- Palo Alto Veterans Instit for Research — Palo Alto, United States (Active)
Researchers
- Principal investigator: Maltzman, Jonathan S — Palo Alto Veterans Instit for Research
- Study coordinator: Maltzman, Jonathan S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.